| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 79.54B | 80.65B | 80.42B | 78.72B | 74.08B | 67.62B |
| Gross Profit | 27.07B | 26.70B | 24.47B | 22.90B | 22.51B | 22.43B |
| EBITDA | 9.30B | 8.67B | 8.75B | 7.86B | 9.17B | 10.03B |
| Net Income | 4.12B | 3.73B | 3.12B | 2.63B | 3.80B | 4.06B |
Balance Sheet | ||||||
| Total Assets | 55.95B | 53.15B | 53.15B | 58.45B | 60.31B | 61.53B |
| Cash, Cash Equivalents and Short-Term Investments | 13.08B | 9.69B | 11.40B | 14.03B | 16.56B | 21.39B |
| Total Debt | 15.25B | 13.52B | 14.06B | 17.92B | 14.02B | 14.01B |
| Total Liabilities | 39.88B | 35.53B | 35.93B | 41.63B | 37.90B | 36.79B |
| Stockholders Equity | 12.78B | 14.23B | 13.89B | 13.37B | 18.66B | 21.11B |
Cash Flow | ||||||
| Free Cash Flow | 4.65B | 4.66B | 1.85B | 1.24B | 2.42B | 6.32B |
| Operating Cash Flow | 7.87B | 8.26B | 5.49B | 4.48B | 5.42B | 8.55B |
| Investing Cash Flow | -2.91B | -2.86B | -3.72B | -3.38B | -4.04B | -2.89B |
| Financing Cash Flow | -4.01B | -4.67B | -7.32B | -4.62B | -6.94B | -1.63B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | HK$134.08B | 9.11 | 14.19% | 6.66% | 5.98% | 62.13% | |
67 Neutral | HK$55.83B | 8.37 | 23.50% | 3.26% | 2.03% | 1.43% | |
65 Neutral | HK$75.08B | 13.61 | 24.09% | 5.46% | -1.68% | 22.06% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
61 Neutral | HK$7.55B | 23.14 | 7.42% | 1.41% | 7.29% | -33.19% | |
56 Neutral | HK$67.16B | 34.73 | 3.79% | 3.62% | -7.36% | -107.25% | |
55 Neutral | HK$32.06B | 8.88 | 7.69% | 6.70% | -0.64% | -24.62% |